Peter C. Trask

Screening for psychologic distress in ambulatory cancer patients

Paul B. Jacobsen, Kristine A. Donovan, Peter C. Trask et al. · Cancer · 2005 · 831 citations · Full text

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Olivier Rixe, Ronald M. Bukowski, M. Dror Michaelson et al. · The Lancet Oncology · 2007 · 434 citations

Urology, Genitourinary Cancer, Medicine +5

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

Hedy L. Kindler, Tatsuya Ioka, D. J. Richel et al. · The Lancet Oncology · 2011 · 393 citations

Gemcitabine Versus Placebo, Oncology, Pancreatic Cancer +7

Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma

Brian I. Rini, George Wilding, Gary R. Hudes et al. · Journal of Clinical Oncology · 2009 · 325 citations · Full text

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Jean‐Philippe Spano, Catherine Chodkiewicz, Joan Maurel et al. · The Lancet · 2008 · 249 citations

Oncology, Pancreatic Cancer, Gastrointestinal Oncology +6